中华胰腺病杂志
中華胰腺病雜誌
중화이선병잡지
CHINESE JOURNAL OF PANCREATOLOGY
2011年
3期
200-202
,共3页
李伟冬%贾林%马军%方建志%邱嘉华%黄耀星%潘锦瑶
李偉鼕%賈林%馬軍%方建誌%邱嘉華%黃耀星%潘錦瑤
리위동%가림%마군%방건지%구가화%황요성%반금요
胰腺炎,急性坏死性%清胰活血汤%Infliximab单抗%腹腔内压%肠屏障功能
胰腺炎,急性壞死性%清胰活血湯%Infliximab單抗%腹腔內壓%腸屏障功能
이선염,급성배사성%청이활혈탕%Infliximab단항%복강내압%장병장공능
Pancreatitis,acute necrotizing%Qingyi Huoxue decoction%Infliximab%Intra-abdomind pressure%Intestinal barrier function
目的 比较清胰活血汤和Infliximab单抗治疗大鼠急性坏死性胰腺炎(ANP)并发多器官功能衰竭(MOOS)的疗效.方法 采用胰管内逆行注射4.5%牛磺胆酸钠1 ml/kg体重的方法诱导大鼠ANP模型.按数字表法随机分为ANP组、清胰活血汤组(Q组)和Infliximab单抗组(Ⅰ组).Ⅰ组于建模后6 h尾静脉注射Infliximab单抗(8 mg/kg体重),ANP组和Q组于建模前4 h和建模后3、9 h分别给予生理盐水和清胰活血汤灌胃(20 ml/kg体重).24 h后处死大鼠,检测血清淀粉酶、总胆红素(TBil)、肌酐(Cr)、TNF-α、二胺氧化酶(DAO)水平,测腹腔内压,计算小肠碳末推进率,行胰腺组织病理学检查.结果 ANP组、Q组、Ⅰ组的胰腺病理评分分别为13.8±0.8、6.1±0.4、3.9±0.6,各组间差异均有统计学意义(P值均<0.05),血清淀粉酶、TBil、Cr及TNF-α水平亦依次显著降低.ANP组、Q组、ΒⅠ组血DAO水平分别为(186.3±10.2)、(134.6±14.3)、(149.1±16.3)U/L;小肠碳末推进率为(53±0.1)%、(89±0.1)%、(61±0.1)%;腹内压为(11.8±1.5)、(4.1±0.8)、(5.8±1.2)mmHg(1 mmHg=0.133 kPa).Q组及Ⅰ组的DAO和腹内压均较ANP组显著降低,而小肠碳末推进率均高于ANP组(P值均<0.05),且Q组小肠碳末推进率高于Ⅰ组,腹内压和DAO浓度低于Ⅰ组,两组的差异具有统计学意义(P值均<0.05).结论 清胰活血汤与Infliximab单抗治疗ANP并MODS大鼠均具显效,其中清胰活血汤在促胃肠动力、降腹内压和改善肠屏障功能方面疗效更显著.
目的 比較清胰活血湯和Infliximab單抗治療大鼠急性壞死性胰腺炎(ANP)併髮多器官功能衰竭(MOOS)的療效.方法 採用胰管內逆行註射4.5%牛磺膽痠鈉1 ml/kg體重的方法誘導大鼠ANP模型.按數字錶法隨機分為ANP組、清胰活血湯組(Q組)和Infliximab單抗組(Ⅰ組).Ⅰ組于建模後6 h尾靜脈註射Infliximab單抗(8 mg/kg體重),ANP組和Q組于建模前4 h和建模後3、9 h分彆給予生理鹽水和清胰活血湯灌胃(20 ml/kg體重).24 h後處死大鼠,檢測血清澱粉酶、總膽紅素(TBil)、肌酐(Cr)、TNF-α、二胺氧化酶(DAO)水平,測腹腔內壓,計算小腸碳末推進率,行胰腺組織病理學檢查.結果 ANP組、Q組、Ⅰ組的胰腺病理評分分彆為13.8±0.8、6.1±0.4、3.9±0.6,各組間差異均有統計學意義(P值均<0.05),血清澱粉酶、TBil、Cr及TNF-α水平亦依次顯著降低.ANP組、Q組、ΒⅠ組血DAO水平分彆為(186.3±10.2)、(134.6±14.3)、(149.1±16.3)U/L;小腸碳末推進率為(53±0.1)%、(89±0.1)%、(61±0.1)%;腹內壓為(11.8±1.5)、(4.1±0.8)、(5.8±1.2)mmHg(1 mmHg=0.133 kPa).Q組及Ⅰ組的DAO和腹內壓均較ANP組顯著降低,而小腸碳末推進率均高于ANP組(P值均<0.05),且Q組小腸碳末推進率高于Ⅰ組,腹內壓和DAO濃度低于Ⅰ組,兩組的差異具有統計學意義(P值均<0.05).結論 清胰活血湯與Infliximab單抗治療ANP併MODS大鼠均具顯效,其中清胰活血湯在促胃腸動力、降腹內壓和改善腸屏障功能方麵療效更顯著.
목적 비교청이활혈탕화Infliximab단항치료대서급성배사성이선염(ANP)병발다기관공능쇠갈(MOOS)적료효.방법 채용이관내역행주사4.5%우광담산납1 ml/kg체중적방법유도대서ANP모형.안수자표법수궤분위ANP조、청이활혈탕조(Q조)화Infliximab단항조(Ⅰ조).Ⅰ조우건모후6 h미정맥주사Infliximab단항(8 mg/kg체중),ANP조화Q조우건모전4 h화건모후3、9 h분별급여생리염수화청이활혈탕관위(20 ml/kg체중).24 h후처사대서,검측혈청정분매、총담홍소(TBil)、기항(Cr)、TNF-α、이알양화매(DAO)수평,측복강내압,계산소장탄말추진솔,행이선조직병이학검사.결과 ANP조、Q조、Ⅰ조적이선병리평분분별위13.8±0.8、6.1±0.4、3.9±0.6,각조간차이균유통계학의의(P치균<0.05),혈청정분매、TBil、Cr급TNF-α수평역의차현저강저.ANP조、Q조、ΒⅠ조혈DAO수평분별위(186.3±10.2)、(134.6±14.3)、(149.1±16.3)U/L;소장탄말추진솔위(53±0.1)%、(89±0.1)%、(61±0.1)%;복내압위(11.8±1.5)、(4.1±0.8)、(5.8±1.2)mmHg(1 mmHg=0.133 kPa).Q조급Ⅰ조적DAO화복내압균교ANP조현저강저,이소장탄말추진솔균고우ANP조(P치균<0.05),차Q조소장탄말추진솔고우Ⅰ조,복내압화DAO농도저우Ⅰ조,량조적차이구유통계학의의(P치균<0.05).결론 청이활혈탕여Infliximab단항치료ANP병MODS대서균구현효,기중청이활혈탕재촉위장동력、강복내압화개선장병장공능방면료효경현저.
Objective To compare the treatment effects of Qingyi Huoxue decoction and infliximab on acute necrosis pancreatitis ( ANP) complicated with MODS in a rat model. Methods 4.5% sodium taurocholate was injected into the pancreatic duct to induce the ANP complicated with MODS model. The ANP rats were randomly divided into 3 groups, ANP group (ANP), Qingyi Huoxue decoction treatment group ( QG) , infliximab treatment group (IG). Rats in infliximab group received infliximab injection at a dose of 8 mg/kg body weight via tail vein 6 h after the ANP induction. The ANP and QG received normal saline and Qingyi Huoxue decoction (20 ml/kg) via gastric lavage 4 h before and 3 h, 9 h after ANP induction. After 24 h, all rats were sacrificed, the serum levels of amylase, total bilirubin, Cr, TNF-α, diamine oxidase ( DAO) , intra-abdominal pressure (IAP) and the rate of carbon propelling rate in ileum were measured. The pancreas samples were collected for pathological examination. The pathological score of pancreas was calculated. Results The pathological scores in ANP, QG, IG were 13.8 ±0.8, 6.1 ±0.4, 3.9 ±0.6, and the difference was statistically significant (P <0.05). The serum levels of amylase, total bilirubin, Cr, TNF-α were significantly decreased. In ANP, QG, IG the serum levels of DAO were (186.3 ± 10.2 ) , ( 134.6 ± 14.3 ) , ( 149.1 ± 16.3) U/L; the carbon propelling rates in ileum were (53 ±0.1)% , (89 ±0.1)% , (61 ±0.1)% ; the IAPs were (11.8 ±1.5), (4.1±0.8), (5.8 ±1.2) mmHg(1 mmHg=0.133 kPa). The DAO and IAP in AG, IG were significantly decreased when compared with that in ANP group, but the carbon propelling rates in ileum was significantly higher than that in ANP group, and the difference was statistically significant ( P < 0.05). In addition, the carbon propelling rates in ileum in QG were higher than that in IG, and IAP and DAO levels were lower than that in IG, and the difference was statistically significant (P <0.05). Conclusions The Qingyi Huoxue decoction and infliximab were significantly effective in the treatment of ANP rats complicated with MODS. But the effects of Qinyi Huoxue decoction on promoting gastrointestinal motility, reducing the IAP and improving the intestinal barrier function were better than those of the infliximab.